Endangering the War on Terror by the War on Drugs
Deepak Lal
Volume 9, Number 3, 2008, pages 1 - 30
The century-old US War on Drugs based on supply control measures is endangering its War on Terror in Afghanistan. With opium poppy cultivation the most profitable crop available to Afghan farmers, the Taliban has been able to use the illegal profits from the trade to buy arms and recruit farmers by ... Read more
Full summary |
Full text (PDF)
HIV/AIDS: A Growing Concern to Business
David E. Bloom, Lakshmi Reddy Bloom, Paul De Lay, Fiona Paua, Richard Samans & Mark Weston
Volume 8, Number 4, 2007, pages 125 - 141
Recent years have seen calls for the private sector to become more involved in the fight against HIV/AIDS. Business has valuable skills and other resources that could assist government and civil society efforts, and some firms (although by no means all) also have strong reasons for involvement. HIV/ ... Read more
Full summary |
Full text (PDF)
Economic, Neurobiological and Behavioral Perspectives on Building America’s Future Workforce
Eric Knudsen, James J. Heckman, Judy Cameron & Jack P. Shonkoff
Volume 7, Number 3, 2006, pages 17 - 41
A growing proportion of the US workforce will have been raised in disadvantaged environments that are associated with relatively high proportions of individuals with diminished cognitive and social skills. A cross-disciplinary examination of research in economics, developmental psychology, and neuro ... Read more
Full summary |
Full text (PDF)
The Value of Vaccination
David E. Bloom, David Canning & Mark Weston
Volume 6, Number 3, 2005, pages 15 - 39
Despite advances during the twentieth century, immunization coverage is far from universal and faces significant obstacles in both developing and developed countries. Weak policy emphasis on vaccination may be the result of the narrow view of its benefits in scientific and policy-making communities, ... Read more
Full summary |
Full text (PDF)
Measures of Progress and Other Tall Stories
From income to anthropometrics
John Komlos & Brian Snowdon
Volume 6, Number 2, 2005, pages 87 - 135
How should progress be measured? Today, economists and economic historians have available a rich array of data for a large number of countries on which to base their response to this important question. The need for alternative measures of the standard of living is particularly important for economi ... Read more
Full summary |
Full text (PDF)
The Anomalous Case of HIV/AIDS
A critical response to Clive Bell & Maureen Lewis,
‘The Economic Implications of Epidemics Old and New’
Barrie Craven, Christian Fiala, Etienne de Harven & Gordon Stewart
Volume 6, Number 1, 2005, pages 119 - 133
In a recent issue of World Economics (Vol. 5, No. 4, 2004) Bell and Lewis discuss
‘The Economic Implications of Epidemics Old and New’. In their article those
authors examine several historic and recent epidemics including HIV/AIDS,
currently regarded as the greatest threat to economic and human ... Read more
Full summary |
Full text (PDF)
The Economic Implications of Epidemics Old and New
Clive Bell & Maureen Lewis
Volume 5, Number 4, 2004, pages 137 - 174
The outbreak of Severe Acute Respiratory Syndrome (SARS) in the winter of
2002–03 raised the specter of a new, unknown and uncontrollable infectious
disease that spreads quickly and is often fatal. Certain branches of economic
activity, notably tourism, felt its impact almost at once, and investo ... Read more
Full summary |
Full text (PDF)
The Health and Wealth of Africa
David E. Bloom & David Canning
Volume 5, Number 2, 2004, pages 57 - 81
Among Africa’s problems, chronic poverty and poor health stand out. Traditional
development thinking has maintained that health improvements are a
consequence of income growth. But new evidence shows that investing in health,
with the aid of the international community, could make a big differenc ... Read more
Full summary |
Full text (PDF)
How Demographic Change can Bolster Economic Performance in Developing Countries
David E. Bloom & David Canning
Volume 4, Number 4, 2003, pages 1 - 14
Falling mortality rates spurred by medical, nutritional and lifestyle changes have
spurred a ‘demographic transition’ in a majority of the world’s countries. As couples
realize their children are more likely to survive, they need, and eventually have,
fewer of them to attain their desired family ... Read more
Full summary |
Full text (PDF)
Regulating Tobacco in the United States
The Government and the Courtroom
Jonathan Gruber
Volume 3, Number 3, 2002, pages 27 - 53
There has been a dramatic turn of events against the tobacco industry in the past
few years, raising the question of the appropriate future path for smoking policy
in the US. This paper discusses the theory and evidence on regulation of
smoking. The author begins by reviewing the background on th ... Read more
Full summary |
Full text (PDF)
Measuring Global Drug Markets
How good are the numbers and why should we care about them?
Peter Reuter & Victoria Greenfield
Volume 2, Number 4, 2001, pages 159 - 173
The continuing demand for measures of the size of global drug revenues has
produced a supply of numbers that consistently overstate international financial
flows. This paper shows that, rather than $500 billion, the annual figure in trade
terms may be about $25 billion. As with many refined agric ... Read more
Full summary |
Full text (PDF)
Prohibition and the Market for Illegal Drugs
An overview of recent history
Suren Basov , Mireille Jacobson & Jeffrey A. Miron
Volume 2, Number 4, 2001, pages 133 - 157
Over the past 25 years in the United States, enforcement of drug prohibition has
expanded dramatically. Over the same period, however, the trends in drug
production and consumption have been essentially flat, and the real, purityadjusted prices of both cocaine and heroin have more than halved. Thi ... Read more
Full summary |
Full text (PDF)
Why is There No AIDS Vaccine?
A new economic explanation
Pedro Rey Biel
Volume 2, Number 4, 2001, pages 117 - 132
This paper provides an economic explanation for the non-existence of a vaccine
against AIDS. It comments on previously claimed economic reasons why private
laboratories do not have incentives to invest in an AIDS vaccine and provides a
new one: private companies already operate in the market for ... Read more
Full summary |
Full text (PDF)